Publications

Publications

Filter Results: (353) Arrow Down
Filter Results: (353) Arrow Down Arrow Up

Show Results For

Show Results For

← Page 17 of 353 Results →
  • 07 Feb 2017
  • First Look

First Look at New Research: February 7

case:https://cb.hbsp.harvard.edu/cbmp/product/517027-PDF-ENG Harvard Business School Case 617-022 Alnylam Pharmaceuticals: Building Value from the IP Estate (B) The leader of a pioneering biotech company in the siRNA space weighs his... View Details
Keywords: Sean Silverthorne
  • 03 May 2011
  • First Look

First Look: May 3

Business Model Gary P. Pisano, Ryan Johnson, and Carin-Isabel KnoopHarvard Business School Case 611-046 In the biotech world, the 18-year-old Munich-based company MorphoSys was a rarity: it was profitable. The company achieved this... View Details
Keywords: Sean Silverthorne
  • 01 Dec 2010
  • News

This Is What I Do

thus deserve our support.” The MJFF raises about $50 million a year. There are prominent backers, such as Google’s Sergey Brin and his wife, Anne Wojcicki, but nearly 55,000 other people made contributions last year. To date the MJFF has supported about ninety View Details
Keywords: Garry Emmons; time travel; Health, Social Assistance; Accommodation; Hospitality; News, Library, Internet, and Other Services; Information; Apparel Manufacturing; Manufacturing
  • 01 Jun 2018
  • News

Up by the Roots

establishing a platform for building relationships among the relevant actors—to be a replicable model of ecosystem development that could be applied anywhere, and to any industry. (At the moment, she is attempting to strike gold twice in one place by boosting New... View Details
Keywords: Alexander Gelfand; illustrations by Dan Page
  • 17 Mar 2009
  • First Look

First Look: March 17, 2009

Download the paper: http://www.hbs.edu/research/pdf/09-099.pdf   Cases & Course MaterialsAvid Radiopharmaceuticals: The Venture Debt Question Harvard Business School Case 809-086 The CEO of a promising biotech company must decide how... View Details
Keywords: Martha Lagace
  • 12 May 2009
  • First Look

First Look: May 12, 2009

this situation, donations are likely to decline, investment surplus has declined and biotech partners are challenged to finance joint projects as well as their own operations. Beall is striving to find a cure for cystic fibrosis while... View Details
Keywords: Martha Lagace
  • 01 Sep 2009
  • News

E Ink’s Wild Ride

that required a massive amount of investment before it could take off,” says Yoffie, who served on E Ink’s board from 1999 to 2004. “The truism is that getting to that point takes longer and costs more money than the most pessimistic forecast. It’s a very similar... View Details
Keywords: Julia Hanna; e-books; e-reading; News, Library, Internet, and Other Services; Information; Computer and Electronic Product Manufacturing; Manufacturing
  • 04 Jun 2007
  • Research & Ideas

Is Health Care Making You Better—or Dead?

technological innovation, which is how the biotechs and some of the medical devices can get through these hurdles. But for a health service innovation, the payment hurdles are so massive it's masochistic. Then if you go into competition... View Details
Keywords: by Sean Silverthorne; Health
  • Web

Past Issues - Alumni

Laura Scher of Working Assets Sharing the Wealth Q & A: Bain & Company's Thomas J. Tierney Tackling a brave new world Complete Table of Contents June 2000 Going Public The Class of 2000 Graduates The Business of Biotech Between the lab... View Details
  • 01 Jun 2007
  • News

Mission Possible

“Rudy contends that if we can identify the other ten or twelve genes that are players, we can give the biotech industry so many more shots to come up with a therapy,” explains McCance, who, along with his cofounders, is privately... View Details
Keywords: Roger Thompson; Margie Kelley; Business Schools & Computer & Management Training; Educational Services; Social Assistance; Health, Social Assistance
  • 28 Aug 2012
  • First Look

First Look: August 28

determining a new venture's future alliance formation diminishes as the new venture's prominence in alliance networks increases. Evidence from biotech alliances between new ventures and established companies provides support for our... View Details
Keywords: Sean Silverthorne
  • Web

Year in Review | Annual Report 2024

closely with leading biotech industry and biomedical authorities, receive programmatic guidance and mentorship, and join a community of entrepreneurs shaping the future of science. To date, the Blavatnik Fellows have created 35 companies... View Details
  • 21 Apr 2009
  • First Look

First Look: April 21, 2009

this case: http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=807106 Note on Biotech Business Development Harvard Business School Note 807-032 Describes the business development process in biotechnology... View Details
Keywords: Martha Lagace
  • 01 May 2007
  • First Look

First Look: May 1, 2007

drug development process; threats from biotech and generics competitors; pharmaceutical manufacturing, selling, and marketing; and pharmaceutical consumption in Europe, the third world, and the U.S. Merck and Pfizer are analyzed in-depth... View Details
Keywords: Sean Silverthorne
  • Web

Print View - Course Catalog

leaders in their respective fields, to offer students a broad range of perspectives as they engage with the coursework. Educational Objectives Through immersing students in Singapore’s burgeoning biotech and technology innovation... View Details
  • 12 Jul 2021
  • News

Alumni Confront the COVID-19 Crisis

PYMNTS.com. (Readers who know of groups in need of PPE can email Miller at anne@projectn95.org.) NOVEMBER 23 Cambridge-based biotech Moderna, led by CEO Stephane Bancel (MBA 2000, AMP 170), released promising results on the coronavirus... View Details